2Sora S, Ueki K, Saito N, et al. Incidence of Von Hippel-Lindau disease in hemangioblastoma patients: the University of Tokyo Hospital experience from 1954 -1998 [J]. Acta Neurochir (Wien) , 2001, 143 (9) : 893 -896.
3GI sker S. Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features [ J]. Fam Cancer, 2005, 4 (1): 37-42.
4GI sker S, Lonser RR, Tran MG, et al. Effects of VHL deficiency on endolymphatic duct and sac [J]. Cancer Res, 2005, 65(23): 10847 - 10853.
2Maher ER, Iselius L, Yates JR, et al. Von Hippel-Lindau disease: a genetic study [J]. J Med Genet, 1991, 28(7) : 443 -447.
3Maddock JR, Moran A, Maher EA, et al. A genetic register for Von Hippel-Lindau disease [J]. J Med Genet, 1996, 33(2): 120-127.
4Tauoli B, Ghouadni M, Correas JM, et al. Spectrum of abdominal imaging findings in yon Hippel-Lindau disease [ J]. Am J Roentgenol, 2003, 181(4): 1049-1054.
5Matsumoto K, Kammuki S. Hemang/oblastoma and yon Hipple-Lindau disease [ J ]. Nippon Rinsho, 1995, 53 ( 11 ) : 2672 - 2677.
6Latif F, Tory K, Gnarra J, et al. Identification of the yon Hippel-Lindau disease tumor suppressor gene [ J ]. Science, 1993, 260 (5112) : 1317 -1320.
7Maher ER, Yates JRW, Harries R, et al. Clinical features and natural history of yon Hippel-Lindau disease [ J ]. Quart J Med, 1990, 77 (283) : 1151 -1163.
8Glasker S, Bender BU, Apel TW, et al. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system [J]. J Neural Neurosurg Psychiatry, 1999, 67(6) : 758 -762.
